In Vivo CRO Market

In Vivo CRO Market Size, Share, Growth Analysis, By Type(Rodent-based, Rats), By GLP Type(Non-GLP, In House), By Indication(Autoimmune/Inflammation Conditions, Rheumatoid Arthritis), By Region(North America, Latin America) - Industry Forecast 2024-2031


Report ID: UCMIG35D2115 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

In Vivo CRO Market Insights

Market Overview:

The market for contract research organizations (CROs) that specialize in in vivo studies on living organisms reached a value of USD 3.9 billion in 2021 on a global scale. Looking ahead, the market is expected to maintain a steady growth trajectory, with a projected compound annual growth rate (CAGR) of 8.2% during the forecast period. This growth can be attributed to the increasing demand for in vivo studies in various fields such as pharmaceuticals, biotechnology, and medical research. The rise in outsourcing of research activities to CROs, driven by cost efficiency and expertise, is also a significant factor contributing to the expansion of the in vivo CRO market.

In Vivo CRO Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Services by segment aggregation, the contribution of the Health Care Services in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The global market for In Vivo CRO was estimated to be valued at US$ XX Mn in 2021.

The global In Vivo CRO Market is estimated to grow at a CAGR of XX% by 2028.

The global In Vivo CRO Market is segmented on the basis of Type, GLP Type, Indication, Region.

Based on region, the global In Vivo CRO Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the global In Vivo CRO Market are , Pharmaceutical Product Development, LLC (PPD) , IQVIA , ICON Plc , Parexel International , American Preclinical Services, LLC , Covance Inc. , Theorem Clinical Research , WuXi AppTec, Inc. , inVentiv Health , Evotec (U.S.), Inc. , Charles River Laboratories .

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

In Vivo CRO Market

Product ID: UCMIG35D2115

$5,300
BUY NOW GET FREE SAMPLE